(firstQuint)Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease.

 This study is a randomized 1:1 placebo-controlled 12-week study of Mirabegron in 144 Parkinson's subjects the age of 40 to 80 with overactive bladder.

 Active drug will be Mirabegron 50mg daily.

 Subjects will be enrolled based on response to an overactive bladder questionnaire at visit 1.

 Enrolled subjects will have 3 study visits to the clinic as well as 1 phone visit.

.

 Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease@highlight

The purpose of this study is to see the study drug, Mirabegron, is safe and effective in treating symptoms of Overactive Bladder in patients with Parkinson's disease.

